• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氟伏沙明致强迫症患者动眼危象和躁狂转换。

Fluvoxamine induced oculogyric dystonia and manic switch in a patient with obsessive compulsive disorder.

机构信息

Department of Psychiatry, Central Institute of Psychiatry, Kanke, Ranchi, Jharkhand, India.

出版信息

Indian J Pharmacol. 2013 Sep-Oct;45(5):532-3. doi: 10.4103/0253-7613.117760.

DOI:10.4103/0253-7613.117760
PMID:24130396
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3793532/
Abstract

Fluvoxamine has a similar spectrum of adverse effects as compared to other selective serotonin reuptake inhibitors. However, fluvoxamine induced oculogyric dystonia is a rare instance in clinical practice. In this report, we present a case of obsessive compulsive disorder that developed oculogyric dystonia during the course of fluvoxamine mono-therapy and subsequently had a manic switch.

摘要

氟伏沙明与其他选择性 5-羟色胺再摄取抑制剂相比,具有相似的不良反应谱。然而,氟伏沙明引起的眼肌痉挛在临床实践中较为罕见。在本报告中,我们介绍了一例强迫症患者,在氟伏沙明单药治疗过程中出现眼肌痉挛,并随后出现躁狂发作。

相似文献

1
Fluvoxamine induced oculogyric dystonia and manic switch in a patient with obsessive compulsive disorder.氟伏沙明致强迫症患者动眼危象和躁狂转换。
Indian J Pharmacol. 2013 Sep-Oct;45(5):532-3. doi: 10.4103/0253-7613.117760.
2
A double-blind study of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder.氟伏沙明与氯米帕明治疗强迫症的双盲研究。
Int Clin Psychopharmacol. 1997 May;12(3):131-6. doi: 10.1097/00004850-199705000-00002.
3
Efficacy of fluvoxamine, paroxetine, and citalopram in the treatment of obsessive-compulsive disorder: a single-blind study.氟伏沙明、帕罗西汀和西酞普兰治疗强迫症的疗效:一项单盲研究。
J Clin Psychopharmacol. 1997 Aug;17(4):267-71. doi: 10.1097/00004714-199708000-00005.
4
An open study of fluvoxamine augmentation of neuroleptics in schizophrenia with obsessive and compulsive symptoms.
Clin Neuropharmacol. 2000 May-Jun;23(3):157-60. doi: 10.1097/00002826-200005000-00005.
5
Dystonic reaction associated with fluvoxamine.
J Clin Psychopharmacol. 1993 Jun;13(3):220-1. doi: 10.1097/00004714-199306000-00014.
6
Serotonin syndrome and fluvoxamine: a case study.血清素综合征与氟伏沙明:一项病例研究。
Nebr Med J. 1996 Apr;81(4):107-9.
7
Fourteen-Pound Fluvoxamine-Associated Weight Gain in a Young Woman with Depression and Multiple Anxiety Symptoms.一名患有抑郁症和多种焦虑症状的年轻女性因服用氟伏沙明增重14磅
J Child Adolesc Psychopharmacol. 2018 Sep;28(7):488-490. doi: 10.1089/cap.2018.29152.bjc.
8
Hair loss associated with fluvoxamine use.
Am J Psychiatry. 1996 Apr;153(4):581-2. doi: 10.1176/ajp.153.4.581.
9
Sulpiride addition in a case of fluvoxamine-refractory obsessive-compulsive disorder without comorbid psychopathology.在一例无共病精神病理学的氟伏沙明难治性强迫症患者中加用舒必利。
J Psychiatry Neurosci. 2000 Mar;25(2):185.
10
Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study.低剂量利培酮增强氟伏沙明治疗强迫症:一项双盲、安慰剂对照研究。
Eur Neuropsychopharmacol. 2005 Jan;15(1):69-74. doi: 10.1016/j.euroneuro.2004.04.004.

本文引用的文献

1
Glutamate and the Treatment of Obsessive-Compulsive Disorder.
Psychopharm Rev. 2010 May 1;45(5):33-40. doi: 10.1097/01.IDT.0000371059.45965.88.
2
The interaction between BDNF and DRD2 in bipolar II disorder but not in bipolar I disorder.双相 II 障碍而非双相 I 障碍中 BDNF 与 DRD2 的相互作用。
Am J Med Genet B Neuropsychiatr Genet. 2012 Jul;159B(5):501-7. doi: 10.1002/ajmg.b.32055. Epub 2012 Apr 18.
3
Pharmacogenomics of antidepressant induced mania: a review and meta-analysis of the serotonin transporter gene (5HTTLPR) association.抗抑郁药诱发躁狂症的药物基因组学:5-羟色胺转运体基因(5HTTLPR)关联的综述和荟萃分析。
J Affect Disord. 2012 Jan;136(1-2):e21-e29. doi: 10.1016/j.jad.2011.05.038. Epub 2011 Jun 15.
4
Extrapyramidal symptoms associated with antidepressants--a review of the literature and an analysis of spontaneous reports.抗抑郁药相关的锥体外系症状——文献综述与自发报告分析
Ann Clin Psychiatry. 2010 Aug;22(3):148-56.
5
Cognition and depression: the effects of fluvoxamine, a sigma-1 receptor agonist, reconsidered.认知与抑郁:重新审视西格玛-1受体激动剂氟伏沙明的作用
Hum Psychopharmacol. 2010 Apr;25(3):193-200. doi: 10.1002/hup.1106.
6
Risk factors for extrapyramidal symptoms during treatment with selective serotonin reuptake inhibitors, including cytochrome P-450 enzyme, and serotonin and dopamine transporter and receptor polymorphisms.选择性5-羟色胺再摄取抑制剂治疗期间锥体外系症状的危险因素,包括细胞色素P-450酶、5-羟色胺和多巴胺转运体及受体多态性。
J Clin Psychopharmacol. 2006 Apr;26(2):192-7. doi: 10.1097/01.jcp.0000203200.96205.34.
7
Oculogyric dystonic reaction to escitalopram with features of anaphylaxis including response to epinephrine.
Int Arch Allergy Immunol. 2006;140(1):27-9. doi: 10.1159/000091840. Epub 2006 Mar 2.
8
Dysphoric mania induced by high-dose mirtazapine: a case for 'norepinephrine syndrome'?高剂量米氮平诱发的烦躁性躁狂:“去甲肾上腺素综合征”病例?
Int Clin Psychopharmacol. 2002 Nov;17(6):319-22. doi: 10.1097/00004850-200211000-00009.
9
Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants.选择性5-羟色胺再摄取抑制剂和三环类抗抑郁药引发的躁狂症
Br J Psychiatry. 1994 Apr;164(4):549-50. doi: 10.1192/bjp.164.4.549.